Viewing Study NCT04008394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-02-09 @ 4:25 AM
Study NCT ID: NCT04008394
Status: UNKNOWN
Last Update Posted: 2019-08-07
First Post: 2019-07-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult T-Cell Lymphoma/Leukaemia View
None Anaplastic Large Cell Lymphoma View
None Angioimmunoblastic T-cell Lymphoma View
None NK/T-cell Lymphoma View
None Peripheral T Cell Lymphoma View
None Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD-30 CART View
None Refractory/Relapsed View
None lymphocyte malignancies View